Related Experiment Video
Updated: Jan 27, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Mucosal Melanoma: Treatment Strategies for a Heterogeneous Disease
Jane Mattei1, Marcio F Chedid2,3,4
1Department of Medical Oncology, The University of Texas at San Antonio, San Antonio (Texas), USA.
Mucosal melanoma (MM), a rare cancer in the respiratory, gastrointestinal, and urogenital tracts, has uncertain origins. Surgical excision is preferred, but lymph node sampling utility is unclear, and treatment responses differ from skin melanoma.
Area of Science:
- Oncology
- Melanoma Research
- Cancer Etiopathogenesis
Background:
- Mucosal melanoma (MM) is a rare but aggressive cancer originating in the non-sun-exposed mucosal linings of the respiratory, gastrointestinal, and urogenital tracts.
- MM accounts for less than 2% of all melanoma diagnoses, with no significant increase in incidence reported.
- The precise etiopathogenesis of mucosal melanoma remains largely unknown, presenting a challenge for targeted therapies.
Related Concept Videos
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

